A validated capillary electrophoretic method for the determination of indacaterol and its application to a pharmaceutical preparation
Indacaterol is a new inhaled ultra-long acting β2-agonist. It has been recently approved in the European Union for the treatment of chronic obstructive pulmonary disease. This paper reports, for the first time, a method for the determination and validation of Indacaterol (IND) using an internal stan...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-04-01
|
Series: | Journal of Food and Drug Analysis |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1021949817301576 |